FDA Drug Application (077066) for NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) by SANDOZ

Back to FDA Applications sponsored by SANDOZ

Application Number077066
Product Number001
FormCAPSULE;ORAL
Dosage75MG;25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)
Active IngredientNITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE

Active IngredientCount
List of drugs with Active Ingredient NITROFURANTOIN5
List of drugs with Active Ingredient NITROFURANTOIN, MACROCRYSTALLINE5


Back to FDA Applications sponsored by SANDOZ